Evidence map›Paper›PMID 26932191›Full record

ArticleEuropean journal of human genetics : EJHG2016

Clinical, neuroradiological and molecular characterization of cerebellar dysplasia with cysts (Poretti-Boltshauser syndrome).

Alessia Micalizzi, Andrea Poretti, Marta Romani, Monia Ginevrino, Tommaso Mazza, Chiara Aiello, Ginevra Zanni, Bastian Baumgartner, Renato Borgatti, Knut Brockmann and 20 more

Open access · bronzeAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
9.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Observational
  12. Article
  13. NGS in Hereditary Ataxia: When Rare Becomes Frequent.International journal of molecular sciences · 2021
    Article
  14. Diagnostic Approach to Cerebellar Hypoplasia.Cerebellum (London, England) · 2021
    Review
  15. Article
  16. Article
  17. An Early Diagnostic Clue forFrontiers in cell and developmental biology · 2021
    Article
  18. Identification ofBrain communications · 2021
    Article
  19. Understanding What You Have Found: A Family With a Mutation in theClinical medicine insights. Case reports · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 20 institutions in 5 countries.

Alessia MicalizziCSS-Mendel Institute, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Andrea PorettiDepartment of Pediatric Neurology, University Children's Hospital, Zurich, Switzerland.
Marta RomaniCSS-Mendel Institute, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Monia GinevrinoCSS-Mendel Institute, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Tommaso MazzaCSS-Mendel Institute, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Chiara AielloLaboratory of Molecular Medicine, Unit of Neuromuscular and Neurodegenerative Disorders, Department of Neurosciences, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Ginevra ZanniLaboratory of Molecular Medicine, Unit of Neuromuscular and Neurodegenerative Disorders, Department of Neurosciences, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Bastian BaumgartnerPediatric Neurology, Children's Hospital, Landshut, Germany.
Renato BorgattiNeuropsychiatry and Neurorehabilitation Unit, Scientific Institute IRCCS Eugenio Medea, Lecco, Italy.
Knut BrockmannInterdisciplinary Pediatric Center for Children with Developmental Disabilities and Severe Chronic Disorders, Department of Pediatrics and Adolescent Medicine, University of Goettingen, Goettingen, Germany.
Ana CamachoSection of Pediatric Neurology, Hospital Universitario 12 de Octubre, Department of Medicine, Universidad Complutense, Madrid, Spain.
Gaetano CantalupoChild Neuropsychiatry, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.ORCID 0000-0003-1343-8434
Martin HaeuslerDepartment of Pediatrics, Division of Neuropediatrics and Social Pediatrics, University Hospital, RWTH Aachen, Aachen, Germany.
Christiane HikelSocial Pediatic Centrum (SPZ), St Vinzenz Hospital, Dinslaken, Germany.
Andrea KleinDepartment of Pediatric Neurology, University Children's Hospital, Zurich, Switzerland.
Giorgia MandrileSCDU Medical Genetics, Hospital Città della Salute e della Scienza di Torino, Turin, Italy.
Eugenio MercuriPaediatric Neurology Unit, Catholic University, Rome, Italy.
Dietz RatingPediatrics, St Marien and St Anna Hospital, Ludwigshafen, Germany.
Romina RomanielloNeuropsychiatry and Neurorehabilitation Unit, Scientific Institute IRCCS Eugenio Medea, Lecco, Italy.
Filippo Maria SantorelliMolecular Medicine, IRCCS Stella Maris, Pisa, Italy.
Mareike SchimmelDivision of Pediatric Neurology, Children's Hospital, Klinikum Augsburg, Augsburg, Germany.
Luigina SpacciniClinical Genetic Unit, Department of Women, Mother and Neonates, 'Vittore Buzzi' Children Hospital, Istituti Clinici di Perfezionamento, Milan, Italy.
Serap TeberDepartment of Pediatric Neurology, Ankara Pediatrics, Hematology-Oncology Training and Research Hospital, Ankara, Turkey.
Arpad von MoersDepartment of Pediatrics, DRK Kliniken Berlin Westend, Berlin, Germany.
Sarah WenteInterdisciplinary Pediatric Center for Children with Developmental Disabilities and Severe Chronic Disorders, Department of Pediatrics and Adolescent Medicine, University of Goettingen, Goettingen, Germany.
Andreas ZieglerDivision of Pediatric Neurology, University Children's Hospital Heidelberg, Germany.
Andrea ZontaSCDU Medical Genetics, Hospital Città della Salute e della Scienza di Torino, Turin, Italy.
Enrico BertiniLaboratory of Molecular Medicine, Unit of Neuromuscular and Neurodegenerative Disorders, Department of Neurosciences, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Eugen BoltshauserDepartment of Pediatric Neurology, University Children's Hospital, Zurich, Switzerland.
Enza Maria ValenteCSS-Mendel Institute, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.ORCID 0000-0002-0600-6820
Bambino Gesù Children's Hospital · ITCasa Sollievo della Sofferenza · ITAzienda Ospedaliera Citta' della Salute e della Scienza di Torino · ITCenter for Children · USIRCCS Eugenio Medea · ITUniversity Children's Hospital Zurich · CHDRK Kliniken Berlin · DEFondazione Stella Maris · ITHeidelberg University · DEHospital Universitario 12 De Octubre · ESIstituti Clinici di Perfezionamento · ITJohns Hopkins University · USRWTH Aachen University · DESt. Marien- und St. Annastiftskrankenhaus · DEUniversità Cattolica del Sacro Cuore · ITUniversity Hospital Augsburg · DEUniversity of Applied Sciences Landshut · DEUniversity of Messina · ITUniversity of Salerno · ITUniversity of Verona · IT

Funding

European Research Council 260888
6 · The paper itself

Abstract

Cerebellar dysplasia with cysts and abnormal shape of the fourth ventricle, in the absence of significant supratentorial anomalies and of muscular involvement, defines recessively inherited Poretti-Boltshauser syndrome (PBS). Clinical features comprise non-progressive cerebellar ataxia, intellectual disability of variable degree, language impairment, ocular motor apraxia and frequent occurrence of myopia or retinopathy. Recently, loss-of-function variants in the LAMA1 gene were identified in six probands with PBS. Here we report the detailed clinical, neuroimaging and genetic characterization of 18 PBS patients from 15 unrelated families. Biallelic LAMA1 variants were identified in 14 families (93%). The only non-mutated proband presented atypical clinical and neuroimaging features, challenging the diagnosis of PBS. Sixteen distinct variants were identified, which were all novel. In particular, the frameshift variant c.[2935delA] recurred in six unrelated families on a shared haplotype, suggesting a founder effect. No LAMA1 variants could be detected in 27 probands with different cerebellar dysplasias or non-progressive cerebellar ataxia, confirming the strong correlate between LAMA1 variants and PBS.

Indexed as

AdolescentCerebellar AtaxiaCerebellumChildChild, PreschoolCystsEye DiseasesFemaleFounder EffectFrameshift MutationHaplotypesHumansInfantIntellectual DisabilityLamininMaleLamininlaminin A

Identifiers

PMID26932191
PMCPMC4913877
OpenAlexW2317264608

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.